Navigation Links
Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
Date:4/26/2011

PAREXEL International Corporation, ClinTrials Research, Inc., Glaxo, Inc. and Glaxo Wellcome, Inc. Dixon holds a bachelor's degree in biology from Campbell University in North Carolina. He is a member of the Board of Directors of Frederick Memorial Healthcare System in Frederick, Maryland, the Drug Information Association (DIA) and the Society of Quality Assurance (SQA).

About Cetero Research

Cetero Research, the leading early-phase contract research organization (CRO), has conducted more than 20,000 clinical pharmacology studies, more than any other CRO. With facilities across North America, Cetero offers flexible, high-quality clinical development services in a range of therapeutic areas, including asthma and allergy, dermatology and diabetes, as well as bioanalytical services to support clinical, preclinical drug and biomarker analysis for small and large molecules. It uses innovative approaches, such as the Accelerated Proof-of-Concept study design to provide key decision-making data earlier in the development process. A pioneer in the pharmaceutical and biotechnology industries, Cetero prioritizes ensuring the safety of its patient and normal healthy study participants, reporting high-quality, reliable data and providing on-time results. For more information, visit www.cetero.com or call 877.7CETERO


'/>"/>
SOURCE Cetero Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cetero Research Leads Industry in Human Allergy Models
2. Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
3. Cetero Research Names Dr. Roger Hayes President of Bioanalytical Operations
4. Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study
5. Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
9. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
10. Video: New Research Discovers Independent Brain Networks Control Human Walking
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015  Essentialis, a venture-backed company ... for the treatment of orphan neurobehavioral and metabolic diseases, today ... CSO, will present a corporate update at the Cantor Fitzgerald ... Date: Wednesday, July 8, 2015 Time: 8:00 ... About Essentialis, Inc. Essentialis ...
(Date:7/7/2015)... , July 7, 2015 Oramed ... a clinical-stage pharmaceutical company focused on the development of ... signed a non-binding Letter of Intent (LoI) for an ... with Sinopharm Capital Management Co. Ltd. and Hefei ... Ltd. (Sinopharm/ Hefei ) potentially valued at ...
(Date:7/6/2015)... July 6, 2015  Student-athletes at community colleges ... from a recently established partnership between ImPACT Applications, ... . The partnership enables member institutions of ... ImPACT ® concussion baseline and post-injury testing ... of community colleges in California ...
Breaking Medicine Technology:Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 3Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 4Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 5California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 2California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 3
(Date:7/7/2015)... ... ... Point is holding an onsite job fair to hire 400 people for its new site ... upcoming Wednesday, July 8, and Thursday, July 9, from 9:00 a.m. – 5:00 p.m. , ... well as holding onsite interviews. Interested parties are encouraged to attend the job fair ...
(Date:7/7/2015)... ... July 07, 2015 , ... Each year the Holiday Inn ... on a local, national and international level; however, the Holiday Inn now hosts one ... a high impact on the beneficiaries. In September of 2014 they hosted an event ...
(Date:7/6/2015)... Yorba Linda, CA (PRWEB) , ... July 06, ... ... human biology into the pre-clinical stages of drug discovery. iPSCs are generated from ... potential to differentiate into any cell type in the human body. , ...
(Date:7/6/2015)... ... ... “ TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... visualize what rooms will look like before they even start renovating.. , Whether a ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female ... time they turn age 35 a quarter of all women in the U.S. will suffer from ... is stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed ...
Breaking Medicine News(10 mins):Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 2Health News:The Holiday Inn Westbury - Long Island Will Host a Fundraising Event on September 16th 2015 from 6:00 pm - 10:00 pm to Benefit Angela's House located on Long Island 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2
... geographical areas in Southeast England according to a new study ... Health . The study shows that the occurrence of cervical ... Currin and her colleagues at the Thames Cancer Registry of ... cancer diagnosed between 2001 and 2005 in London, Kent, Surrey ...
... and programming in Canadian long-term care facilities fall short ... , Led by professor of Community Health and Epidemiology ... is the first comprehensive examination of these resources and ... that vulnerable long-term care residents be protected from largely ...
... 19 Esphera3 International (E3I) is a broad ... of "Patient Focused Care." Currently engaged in multiple ... of a partnered care health approach including operational ... financial operations of healthcare.E3I and its channel partners ...
... SHELBY TOWNSHIP, Mich., Feb. 19 Dr. Brett Kotlus ... Allure Medical Blog to share information,about new ... their practice. "I find that patients at our ... to sort through the tremendous,amount of information available on ...
... save lives and reduce disability, but less than 3% of ... (HealthDay News) -- A powerful clot-busting drug approved by the ... in 1996 is still rarely used in Medicare patients, new ... 495,000 admissions for stroke at the 4,750 hospitals evaluated were ...
... Insulet Corporation, (Nasdaq: PODD ), the leader ... Management System, announced plans to release its financial results ... Thursday, March 5, 2009 after the close of the ... 5:00 p.m. Eastern Time on Thursday, March 5, 2009 ...
Cached Medicine News:Health News:Infection prevention falls short in Canadian long-term care facilities 2Health News:Esphera3 International Founded on 'Patient Focused Care' 2Health News:Your Doctor Has a Blog 2Health News:Your Doctor Has a Blog 3Health News:Few Stroke Patients Get Clot-Busting Drug 2Health News:Few Stroke Patients Get Clot-Busting Drug 3
Threaded cannula with cannulated obturator for use with Acufex Suture Punch; sterile packs, box of 10....
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
...
...
Medicine Products: